SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...